Main Content

Myxoinflammatory Fibroblastic Sarcoma

Myxoinflammatory fibroblastic sarcoma (MIFS) is an infiltrative, locally aggressive fibroblastic neoplasm that typically arises in the distal extremities. It is characterized by pleomorphic fibroblastic cells with macronucleoli in a myxohyaline background with a variably prominent inflammatory cell infiltrate.

Symptoms & Causes

Introduction

Myxoinflammatory fibroblastic sarcoma (MIFS) is a locally aggressive fibroblastic tumor found in distal extremities, characterized by pleomorphic cells in a myxohyaline matrix and a prominent inflammatory infiltrate.

Reference
WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours [Internet]. Lyon (France): International Agency for Research on Cancer; 2020 [cited 2024 09 11]. (WHO classification of tumours series, 5th ed.; vol. 3). Available from: https://tumourclassification.iarc.who.int/chapters/33.

Related Terminology
Not recommended: inflammatory myxohyaline tumor of the distal extremities with virocyte-like or Reed–Sternberg–like cells; acral myxoinflammatory fibroblastic sarcoma; inflammatory myxoid tumor of the soft parts with bizarre giant cells.

Subtype(s)
None

Symptoms

These neoplasms present as solitary painless masses, typically of the distal extremities. Most examples measure about 3 cm, but the size range is wide. On imaging, they are centered in the subcutis (about two thirds) or deeper and typically display infiltration into adjoining tissues such that they mimic infection, tenosynovial giant cell tumor, or ganglion cysts.

Localization

MIFS usually affects the acral dorsal extremities, particularly the hands, but occasional proximal examples have been highlighted and accounted for about 5% of cases in the largest series to date. The hand, finger, and wrist account for about 60% of cases, and the foot and ankle for about 20%.

Epidemiology

These are rare neoplasms. The reported age range is 4–91 years (median: ~40 years), with no sex predilection.

Etiology

Unknown

Diagnosis & Treatment

Staging

Not clinically relevant

Pathogenesis

Tumors showing histological overlap with MIFS and haemosiderotic fibrolipomatous tumor (HFLT) have been reported, suggesting a link between these two tumor types, but this link remains incompletely understood and controversial. MIFSs have also been reported to coexist with pleomorphic hyalinizing angiectatic tumor, but the precise classification of these unusual tumors remains the subject of debate.
A complex karyotype including a reciprocal t(1;10)(p22;q24) was initially reported in MIFS, followed by a report of a reciprocal t(1;10) in a case of HFLT and a hybrid MIFS/HFLT with der(10)t(1;10). The breakpoints in chromosomes 1 and 10 cluster in TGFBR3 and in or near OGA (MGEA5), respectively, but do not result in an expressed fusion gene. The t(1;10) has been detected in most HFLT cases and appears much more common in hybrid HFLT-MIFS tumors than in classic MIFS. Although these findings resulted in the proposal of an initial pathogenetic link between MIFS and HFLT, suggesting that they represent a morphological continuum or pathological spectrum, later studies have questioned this hypothesis, postulating that these two entities are unrelated and that hybrid HFLT-MIFS tumors more likely represent sarcomatous progression in HFLT, rather than true MIFS. Additionally, one third of MIFSs demonstrate BRAF-related fusions, which were not detected in any of the HFLTs tested. Another common genetic event in both MIFS and HFLT is the presence of a 3p11.1-p12.1 amplicon, including the VGLL3 gene.

Macroscopic Appearance

Tumors are lobulated and variably gelatinous, fleshy, or firm, typically attaining a size of roughly 3 cm.

Histopathology

These tumors are infiltrative and multinodular, being centered in the subcutaneous tissue in most cases. They are characterized histologically by dense inflammation merging with stroma varying from myxoid to hyalinized and containing sheets and small foci of epithelioid and spindled cells. Some lesions contain foamy histiocytes, giant cells, and haemosiderin. The cellularity is quite variable between lesions. Amid the inflammatory background, scattered bizarre cells with large vesicular nuclei and macronucleoli reminiscent of Reed–Sternberg cells or virocytes are present. Many cells show degenerated smudged chromatin. Pseudolipoblasts akin to those encountered in myxofibrosarcoma with cytoplasmic mucopolysaccharide matrix compressing nuclei may be seen. The spindle cells often coalesce at the periphery of myxoid lobules to form a reticular pattern as they merge with myxoid tissue. The inflammatory infiltrate is mixed, consisting of lymphocytes, plasma cells, histiocytes, and eosinophils in varying proportions. Emperipolesis may be present. Despite the cytological atypia, mitotic activity is minimal. Immunohistochemistry is unhelpful.

Cytology

Cytological preparations show large epithelioid cells with macronucleoli and lipoblast-like features enmeshed in myxoid stroma with prominent inflammation and spindle cells.

Prognosis and Prediction

Local recurrences are common and often repeated. Metastases are rare, occurring in < 1% of cases after multiple recurrences. Initial complete excision is the best predictor of a favorable outcome.

Clinical Features

Diagnostic Molecular Pathology

Not clinically relevant

Essential and Desirable Diagnostic Criteria

Essential: typical distal extremity location; atypical fibroblastic cells with macronucleoli; variably myxoid and hyalinized matrix with a mixed inflammatory infiltrate.

Desirable: pseudolipoblasts.

ribbon

Make a Donation

Help us move closer to a world where people do not die from sarcoma

Make a Donation
ribbon

section